Rocket One Inc. Investment Income, Dividend
Rocket One Inc. (RKTO) reported Investment Income, Dividend of $149 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2026-05-15
- Rocket One Inc. investment income, dividend for the quarter ending 2026-03-31 was $149.00, a 17.68% decline year-over-year.
- Rocket One Inc. investment income, dividend for the quarter ending 2025-12-31 was $158.00, a 17.71% decline year-over-year.
- Rocket One Inc. investment income, dividend for the quarter ending 2025-09-30 was $168.00, a 16.00% decline year-over-year.
- Rocket One Inc. investment income, dividend for the quarter ending 2025-06-30 was $173.00, a 98.71% decline year-over-year.
- Rocket One Inc. investment income, dividend for fiscal 2025 was $680.00, a 97.55% decline from fiscal 2024.
- Rocket One Inc. investment income, dividend for fiscal 2024 was $27.71K, a 46.47% decline from fiscal 2023.
- Rocket One Inc. investment income, dividend for fiscal 2023 was $51.77K.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month | Investment Income, Dividend 9 month | Investment Income, Dividend 12 month |
|---|---|---|---|---|
| 2026-03-31 | $149.00 10-Q · filed 2026-05-15 | $307.00 derived: sum of 2 quarters · filed 2026-05-15 | $475.00 derived: sum of 3 quarters · filed 2026-05-15 | $648.00 derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $158.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $326.00 derived: sum of 2 quarters · filed 2026-03-27 | $499.00 derived: sum of 3 quarters · filed 2026-03-27 | $680.00 10-K · filed 2026-03-27 |
| 2025-09-30 | $168.00 10-Q · filed 2025-11-12 | $341.00 derived: sum of 2 quarters · filed 2025-11-12 | $522.00 10-Q · filed 2025-11-12 | $714.00 derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $173.00 10-Q · filed 2025-08-12 | $354.00 10-Q · filed 2025-08-12 | $546.00 derived: sum of 3 quarters · filed 2026-05-15 | $746.00 derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $181.00 10-Q · filed 2026-05-15 | $373.00 derived: sum of 2 quarters · filed 2026-05-15 | $573.00 derived: sum of 3 quarters · filed 2026-05-15 | $13.94K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $192.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $392.00 derived: sum of 2 quarters · filed 2026-03-27 | $13.76K derived: sum of 3 quarters · filed 2026-03-27 | $27.71K 10-K · filed 2026-03-27 |
| 2024-09-30 | $200.00 10-Q · filed 2025-11-12 | $13.56K derived: sum of 2 quarters · filed 2025-11-12 | $27.52K 10-Q · filed 2025-11-12 | $44.02K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $13.37K 10-Q · filed 2025-08-12 | $27.32K 10-Q · filed 2025-08-12 | $43.82K derived: sum of 3 quarters · filed 2025-08-12 | $49.43K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $13.96K 10-Q · filed 2025-05-12 | $30.46K derived: sum of 2 quarters · filed 2025-05-12 | $36.07K derived: sum of 3 quarters · filed 2025-05-12 | $37.62K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $16.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $22.11K derived: sum of 2 quarters · filed 2025-03-28 | $23.66K derived: sum of 3 quarters · filed 2025-03-28 | $51.77K 10-K · filed 2025-03-28 |
| 2023-09-30 | $5.61K 10-Q · filed 2024-11-12 | $7.16K derived: sum of 2 quarters · filed 2024-11-12 | $35.27K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.55K 10-Q · filed 2024-08-09 | $29.66K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |